Stockreport

FDA grants RMAT status for Voyager's VY-AADC gene therapy for Parkinson's [Seeking Alpha]

Voyager Therapeutics, Inc.  (VYGR) 
Last voyager therapeutics, inc. earnings: 3/3 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.voyagertherapeutics.com
PDF The FDA grants Regenerative Medicine Advanced Therapy (RMAT) status for Voyager Therapeutics' (NASDAQ: VYGR ) VY-AADC gene therapy for the treatment of Parkinso [Read more]